|
2
|
92
|
1dz7A |
Solution structure of the a-subunit of human chorionic gonadotropin [modeled without carbohydrate residues] |
|
3
|
92
|
1hd4A |
Solution structure of the a-subunit of human chorionic gonadotropin [modeled with diantennary glycan at asn78] |
|
9
|
112
|
1klaA |
Solution structure of tgf-b1, nmr, models 1-17 of 33 structures |
|
3
|
92
|
1e9jA |
Solution structure of the a-subunit of human chorionic gonadotropin [including a single glcnac residue at asn52 and asn78] |
|
9
|
99
|
1katW |
Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor |
|
11
|
95
|
4hqxA |
Crystal structure of human pdgf-bb in complex with a modified nucleotide aptamer (somamer sl4) |
|
12
|
95
|
4hquA |
Crystal structure of human pdgf-bb in complex with a modified nucleotide aptamer (somamer sl5) |
|
15
|
104
|
4zbnA |
Non-helical dna triplex forms a unique aptamer scaffold for high affinity recognition of nerve growth factor |
|
16
|
110
|
5jz7A |
Ngf in complex with medi578 scfv |
|
15
|
95
|
5hhdA |
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21 |
|
15
|
104
|
4uhzA |
Crystal structure of the human rgmb-bmp2 complex, crystal form 1 |
|
7
|
102
|
5bq8D |
Crystal structure of norrin, a wnt signalling activator, crystal form ii |
|
9
|
100
|
5bqcA |
Crystal structure of norrin in complex with the cysteine-rich domain of frizzled 4 and sucrose octasulfate |
|
7
|
111
|
5bpuA |
Crystal structure of norrin, a wnt signalling activator, crystal form i |
|
8
|
104
|
5bq8A |
Crystal structure of norrin, a wnt signalling activator, crystal form ii |
|
16
|
114
|
5aejA |
Crystal structure of human gremlin-1 |
|
19
|
105
|
4faoA |
Specificity and structure of a high affinity activin-like 1 (alk1) signaling complex |
|
14
|
108
|
4edwV |
Nerve growth factor in complex with fab from humanized version of mouse mab 911 (tanezumab) |
|
8
|
107
|
4edxV |
Nerve growth factor in complex with fab from mouse mab 911 |
|
12
|
108
|
4efvA |
Crystal structure of oif from llama seminal plasma |
|
15
|
108
|
4ec7A |
Cobra ngf in complex with lipid |
|
15
|
108
|
4eaxA |
Mouse ngf in complex with lyso-ps |
|
7
|
99
|
4bv4L |
Structure and allostery in toll-spatzle recognition |
|
8
|
88
|
4ay9A |
Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor |
|
7
|
107
|
4ay9B |
Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor |
|
14
|
94
|
3v6bA |
Vegfr-2/vegf-e complex structure |
|
13
|
95
|
3v2aA |
Vegfr-2/vegf-a complex structure |
|
16
|
109
|
3sekB |
Crystal structure of the myostatin:follistatin-like 3 complex |
|
15
|
96
|
3s1bV |
The development of peptide-based tools for the analysis of angiogenesis |
|
15
|
95
|
3s1kV |
The development of peptide-based tools for the analysis of angiogenesis |
|
61
|
362
|
3rjrA |
Crystal structure of pro-tgf beta 1 |
|
6
|
97
|
5bq8B |
Crystal structure of norrin, a wnt signalling activator, crystal form ii |
|
8
|
101
|
5bqeA |
Crystal structure of norrin in complex with the cysteine-rich domain of frizzled 4 -methylated form |
|
5
|
101
|
5bqeB |
Crystal structure of norrin in complex with the cysteine-rich domain of frizzled 4 -methylated form |
|
9
|
99
|
5bqbA |
Crystal structure of norrin, a wnt signalling activator, crystal form iii |
|
10
|
138
|
5hk5E |
Structure of the grem2-gdf5 inhibitory complex |
|
13
|
90
|
5hhvA |
Inhibiting complex il-17a and il-17ra interactions with a linear peptide |
|
13
|
110
|
5hi3A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
12
|
93
|
5hhxA |
Inhibiting complex il-17a and il-17ra interactions with a linear peptide |
|
16
|
96
|
4zffC |
Dual-acting fab 5a12 in complex with vegf |
|
15
|
95
|
5hhcA |
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21/n |
|
16
|
105
|
5hk5A |
Structure of the grem2-gdf5 inhibitory complex |
|
11
|
108
|
5hi5A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
13
|
91
|
5hi4A |
Binding site elucidation and structure guided design of macrocyclic il-17a antagonists |
|
13
|
96
|
5fv2V |
Crystal structure of hvegf in complex with vh domain antibody |
|
14
|
95
|
5fv1V |
Crystal structure of hvegf in complex with vk domain antibody |
|
11
|
108
|
5f3hI |
Structure of myostatin in complex with humanized rk35 antibody |
|
13
|
109
|
5f3bC |
Structure of myostatin in complex with chimeric rk35 antibody |
|
23
|
108
|
5e4gA |
Crystal structure of human growth differentiation factor 11 (gdf-11) |
|
22
|
105
|
4yciC |
Non-latent pro-bone morphogenetic protein 9 |
